Peptable

Comparison

Exenatide vs Melanotan I

Function

While Exenatide is used for type 2 diabetes treatment to improve glycemic control and modestly reduce body weight through GLP-1–like insulinotropic and glucagonostatic effects6768, Melanotan I is approved in some regions for prevention of phototoxicity in erythropoietic protoporphyria and is studied as a skin-darkening, photoprotective peptide3444.

Mechanism

While Exenatide works as a 39-amino-acid exendin-4 peptide originally isolated from Gila monster venom that acts as a long-acting GLP-1 receptor agonist resistant to DPP-4 degradation67, Melanotan I is a linear 13-amino-acid analog of α-MSH (afamelanotide) that selectively activates MC1R on melanocytes, increasing eumelanin synthesis and providing photoprotection3444.

Receptor

Exenatide

GLP-1 receptor (GLP1R) 6780

Melanotan I

Melanocortin-1 receptor (MC1R) 344481

Organism or Origin

Exenatide

Originally from Heloderma suspectum (Gila monster) venom; now produced synthetically67

Melanotan I

Synthetic analog of human α-MSH derived from POMC34448190

Gene

Exenatide

Not assigned in the current dataset.

Melanotan I

POMC

Summary

Both peptides fall into a similar broad context as Hormone peptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: Exenatide is more often discussed in the realm of Metabolic and endocrine, whereas Melanotan I is more often associated with the realm of Dermatology and aesthetics. Both appear to work through Receptor agonist, but the functional emphasis still separates, with Exenatide leaning toward Metabolic regulation and Melanotan I leaning toward Melanogenesis modulation. Exenatide has a more venom-derived origin, while Melanotan I is closer to synthetic analog background and their development context also differs, with Exenatide approved while Melanotan I is approved for Research use only. Exenatide carries amidation features, while Melanotan I instead reflects d-amino acid substitution changes, while their sequence patterns also diverge, with Exenatide showing alpha-helical domain features and Melanotan I showing protein-mimetic sequence features.

Sources

67Exendin 4 – Potent GLP-1R agonist - SB PEPTIDE, https://www.sb-peptide.com/project/exendin-4-potent-glp-1r-agonist/
68Glucagon-like peptide-1 analogues: An overview - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC3712370/
80GLP-1 Localisation and Proglucagon Gene Expression in ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC6200298/
34Melanotan I (Afamelanotide): Research Profile - PeptideJournal, https://www.peptidejournal.org/peptides/melanotan-i-research-profile
44Melanotan I: properties, applications and references, https://www.benchchem.com/zh/product/b1666627
81Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC2253185/
90alpha-Melanocyte stimulating hormone: production and degradation, https://pmc.ncbi.nlm.nih.gov/articles/PMC3936413/